Download App
Earn CPD/CME Points
Gain certification upon completion
Learn-on-Demand
Advancing Targeted Therapy in Acute Myeloid Leukemia (AML) with Quizartinib
This CME presents an expert interview on targeted therapy in FLT3-ITD–positive AML, focusing on clinical evidence for quizartinib and its application in clinical practice.... See more
CME/CPD:
CME Unit: 1 point
Expiry:
17 Jun 2027